2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/146998 |
Resumo: | Objective: To elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. Method: Literature review with articles’ selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. Results and conclusions: 1) The therapeutic decision should be shared with the patient; 2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; 3) treatment should be conducted by a rheumatologist; 4) the initial treatment includes synthetic DMARDs; 5) methotrexate is the drug of choice; 6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; 7) exceptionally, biologic DMARDs can be considered earlier; 8) anti-TNF agents are preferentially recommended as the initial biologic therapy; 9) after therapeutic failure of a fi rst biologic DMARD, other biologics can be used; 10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; 11) oral corticoid is recommended at low doses and for short periods of time; 12) non-steroidal anti-infl ammatory drugs should always be prescribed in association with a DMARD; 13) clinical assessments should be performed on a monthly basis at the beginning of treatment; 14) physical therapy, rehabilitation, and occupational therapy are indicated; 15) surgical treatment is recommended to correct sequelae; 16) alternative therapy does not replace traditional therapy; 17) family planning is recommended; 18) the active search and management of comorbidities are recommended; 19) the patient’s vaccination status should be recorded and updated; 20) endemic-epidemic transmissible diseases should be investigated and treated. |
id |
UFRGS-2_2ed98316db1012483b4fcc49deec79af |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/146998 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Pereira, Ivânio AlvesMota, Licia Maria Henrique daCruz, Boris AfonsoBrenol, Claiton ViegasFronza, Lucila Stange RezendeBertolo, Manoel BarrosFreitas, Max Victor Carioca deSilva, Nilzio Antonio daLouzada Junior, PauloGiorgi, Rina Dalva NeubarthLima, Rodrigo Aires CorrêaPinheiro, Geraldo da Rocha Castelar2016-08-10T02:15:31Z20120482-5004http://hdl.handle.net/10183/146998000986379Objective: To elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. Method: Literature review with articles’ selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. Results and conclusions: 1) The therapeutic decision should be shared with the patient; 2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; 3) treatment should be conducted by a rheumatologist; 4) the initial treatment includes synthetic DMARDs; 5) methotrexate is the drug of choice; 6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; 7) exceptionally, biologic DMARDs can be considered earlier; 8) anti-TNF agents are preferentially recommended as the initial biologic therapy; 9) after therapeutic failure of a fi rst biologic DMARD, other biologics can be used; 10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; 11) oral corticoid is recommended at low doses and for short periods of time; 12) non-steroidal anti-infl ammatory drugs should always be prescribed in association with a DMARD; 13) clinical assessments should be performed on a monthly basis at the beginning of treatment; 14) physical therapy, rehabilitation, and occupational therapy are indicated; 15) surgical treatment is recommended to correct sequelae; 16) alternative therapy does not replace traditional therapy; 17) family planning is recommended; 18) the active search and management of comorbidities are recommended; 19) the patient’s vaccination status should be recorded and updated; 20) endemic-epidemic transmissible diseases should be investigated and treated.application/pdfengRevista brasileira de reumatologia. Campinas. Vol. 52, n. 2 (mar./abr. 2012), p. 474-495Artrite reumatóideConsensoTerapêuticaRheumatoid arthritisTherapyBrazilAntirheumatic agentsConsensus2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritisConsenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide info:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000986379.pdf000986379.pdfTexto completo (inglês)application/pdf660192http://www.lume.ufrgs.br/bitstream/10183/146998/1/000986379.pdf085c1c6cf20441e8f89238da14a5975bMD51TEXT000986379.pdf.txt000986379.pdf.txtExtracted Texttext/plain119643http://www.lume.ufrgs.br/bitstream/10183/146998/2/000986379.pdf.txt30a419ed7e85c12563fb0a14b8340416MD52THUMBNAIL000986379.pdf.jpg000986379.pdf.jpgGenerated Thumbnailimage/jpeg1654http://www.lume.ufrgs.br/bitstream/10183/146998/3/000986379.pdf.jpg0e08191839a1046490563a23d32f4a24MD5310183/1469982018-10-29 08:26:06.455oai:www.lume.ufrgs.br:10183/146998Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2018-10-29T11:26:06Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
dc.title.alternative.pt_BR.fl_str_mv |
Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide |
title |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
spellingShingle |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis Pereira, Ivânio Alves Artrite reumatóide Consenso Terapêutica Rheumatoid arthritis Therapy Brazil Antirheumatic agents Consensus |
title_short |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
title_full |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
title_fullStr |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
title_full_unstemmed |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
title_sort |
2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
author |
Pereira, Ivânio Alves |
author_facet |
Pereira, Ivânio Alves Mota, Licia Maria Henrique da Cruz, Boris Afonso Brenol, Claiton Viegas Fronza, Lucila Stange Rezende Bertolo, Manoel Barros Freitas, Max Victor Carioca de Silva, Nilzio Antonio da Louzada Junior, Paulo Giorgi, Rina Dalva Neubarth Lima, Rodrigo Aires Corrêa Pinheiro, Geraldo da Rocha Castelar |
author_role |
author |
author2 |
Mota, Licia Maria Henrique da Cruz, Boris Afonso Brenol, Claiton Viegas Fronza, Lucila Stange Rezende Bertolo, Manoel Barros Freitas, Max Victor Carioca de Silva, Nilzio Antonio da Louzada Junior, Paulo Giorgi, Rina Dalva Neubarth Lima, Rodrigo Aires Corrêa Pinheiro, Geraldo da Rocha Castelar |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Pereira, Ivânio Alves Mota, Licia Maria Henrique da Cruz, Boris Afonso Brenol, Claiton Viegas Fronza, Lucila Stange Rezende Bertolo, Manoel Barros Freitas, Max Victor Carioca de Silva, Nilzio Antonio da Louzada Junior, Paulo Giorgi, Rina Dalva Neubarth Lima, Rodrigo Aires Corrêa Pinheiro, Geraldo da Rocha Castelar |
dc.subject.por.fl_str_mv |
Artrite reumatóide Consenso Terapêutica |
topic |
Artrite reumatóide Consenso Terapêutica Rheumatoid arthritis Therapy Brazil Antirheumatic agents Consensus |
dc.subject.eng.fl_str_mv |
Rheumatoid arthritis Therapy Brazil Antirheumatic agents Consensus |
description |
Objective: To elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. Method: Literature review with articles’ selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. Results and conclusions: 1) The therapeutic decision should be shared with the patient; 2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; 3) treatment should be conducted by a rheumatologist; 4) the initial treatment includes synthetic DMARDs; 5) methotrexate is the drug of choice; 6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; 7) exceptionally, biologic DMARDs can be considered earlier; 8) anti-TNF agents are preferentially recommended as the initial biologic therapy; 9) after therapeutic failure of a fi rst biologic DMARD, other biologics can be used; 10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; 11) oral corticoid is recommended at low doses and for short periods of time; 12) non-steroidal anti-infl ammatory drugs should always be prescribed in association with a DMARD; 13) clinical assessments should be performed on a monthly basis at the beginning of treatment; 14) physical therapy, rehabilitation, and occupational therapy are indicated; 15) surgical treatment is recommended to correct sequelae; 16) alternative therapy does not replace traditional therapy; 17) family planning is recommended; 18) the active search and management of comorbidities are recommended; 19) the patient’s vaccination status should be recorded and updated; 20) endemic-epidemic transmissible diseases should be investigated and treated. |
publishDate |
2012 |
dc.date.issued.fl_str_mv |
2012 |
dc.date.accessioned.fl_str_mv |
2016-08-10T02:15:31Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/other |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/146998 |
dc.identifier.issn.pt_BR.fl_str_mv |
0482-5004 |
dc.identifier.nrb.pt_BR.fl_str_mv |
000986379 |
identifier_str_mv |
0482-5004 000986379 |
url |
http://hdl.handle.net/10183/146998 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Revista brasileira de reumatologia. Campinas. Vol. 52, n. 2 (mar./abr. 2012), p. 474-495 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/146998/1/000986379.pdf http://www.lume.ufrgs.br/bitstream/10183/146998/2/000986379.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/146998/3/000986379.pdf.jpg |
bitstream.checksum.fl_str_mv |
085c1c6cf20441e8f89238da14a5975b 30a419ed7e85c12563fb0a14b8340416 0e08191839a1046490563a23d32f4a24 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447620312629248 |